CN105816565A - Composition for treating enteritis of black carps - Google Patents
Composition for treating enteritis of black carps Download PDFInfo
- Publication number
- CN105816565A CN105816565A CN201610362469.9A CN201610362469A CN105816565A CN 105816565 A CN105816565 A CN 105816565A CN 201610362469 A CN201610362469 A CN 201610362469A CN 105816565 A CN105816565 A CN 105816565A
- Authority
- CN
- China
- Prior art keywords
- group
- parts
- herba
- experiment
- enteritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Farming Of Fish And Shellfish (AREA)
Abstract
The invention belongs to the field of aquaculture and particularly discloses a composition for treating enteritis of black carps .The composition comprises, by mass, 8-12 parts of herbs of denseflower blumea, 8-12 parts of scoparia dulcis L., 4-6 parts of patrinia scabiosifolia fisch .ex Trevir .and 3-5 parts of herbs of common sowthistle .The cure rate of the composition to enteritis of black carps can reach 85% or above .
Description
Technical field
The present invention relates to aquaculture field, be specifically related to a kind of compositions treating Mylopharyngodon piceus enteritis disease.
Background technology
Mylopharyngodon piceus is one of four large Chinese carps, is a kind of high protein, low-fat food, and its protein content is 20.1%, and fat content is
4.2%.In aminoacid forms, rich in glutamic acid, aspartic acid etc. in delicate flavour composition, therefore delicious flavour of tasting.Mylopharyngodon piceus
Pork is thick, and greasiness is delicious, and thorn is big and lacks, and containing the mineral such as saccharide, multivitamin and zinc, calcium, phosphorus, ferrum, magnesium, is
Top grade in fresh-water fishes.Mylopharyngodon piceus is rich in lysine, and general lack of lysine in the daily staple food of people, the most often eats Mylopharyngodon piceus and can send out
Wave protein complementary action, promote the nutritive value of food.
Enteritis disease is one of disease the most serious in China's cultured fishes, and its cause of disease is addicted to aqueous vapor pseudomonas bacillus, for Gram-negative
Bacterium.Suffering from the Mylopharyngodon piceus of enteritis disease to peel off solely trip, slow trip, fish body turns black, few food or do not eat;Abdominal part expands, and presents erythema, anus
Door is red and swollen prominent;Mention disease fish head portion, have faint yellow mucus to flow out from anus;Cutting intestinal tube open, intestinal wall hyperemia inflammation, in enteric cavity
Do not have food or only back segment at intestinal have a small amount of feces, the how faint yellow mucus of enteral, intestinal wall poor flexibility, scale is easy to fall off, causes
Fish mortality, this disease annual 5~June, the Mylopharyngodon piceus endangering for 1~2 ages more.
The method of traditional treatment enteritis disease is: bleaching powder full pond float, makes water become the concentration of lmg/L;Take Herba Euphorbiae Humifusae orally simultaneously,
Fish is fed by Radix Glycyrrhizae 0.5~lkg/100kg, every day 1 time, continuous 5 days.This method to the cure rate of Mylopharyngodon piceus enteritis disease 75%
Left and right.
Summary of the invention
It is an object of the invention to provide a kind of compositions treating Mylopharyngodon piceus enteritis disease, the said composition cure rate to Mylopharyngodon piceus enteritis disease
More than 85% can be reached.
For reaching above-mentioned purpose, the base case of the present invention is: a kind of compositions treating Mylopharyngodon piceus enteritis disease, according to mass fraction
Meter, including Herba Blumeae Densiflorae 8-12 part, Sweet Broomwort Herb 8-12 part, Herba Patriniae 4-6 part, Herba Sonchi Oleracei 3-5 part.
Herba Blumeae Densiflorae has clearing away heat and cooling blood, effect of preventing the attack (or recurrence) of malaria;Cure mainly malaria, enteritis, cat fever.Sweet Broomwort Herb has clearing away heat-damp and promoting diuresis,
Effect that dispelling wind is antipruritic, for enteritis, bacillary dysentery, cold, fever, dysuria;Miliaria, skin eczema are controlled in external.
Herba Patriniae has heat-clearing and toxic substances removing, effect of evacuation of pus removing blood stasis with potent drugs;Control acute appendicitis, dysentery, puerperal the stagnant stomachache of the stasis of blood, carbuncle scabies.Herba Sonchi Oleracei has
Heat-clearing and toxic substances removing, removing blood stasis with potent drugs invigorates blood circulation, effect of evacuation of pus;For appendicitis, peritoneal abscess, enteritis, dysentery, spit blood, epistaxis;Outward
With controlling traumatic injury, furuncle swells and ache, impetigo, eczema scrotum.
The program have the beneficial effect that one be treatment Mylopharyngodon piceus enteritis disease remarkably productive, cure rate reaches more than 85%;Two is choosing
Treat enteritis disease with Chinese herbal medicine, while regulation fish internal milieu balance, increase fish body immunity, improve Mylopharyngodon piceus and resist it
The ability of his disease.
Prioritization scheme one: the optimization as to base case: according to mass fraction meter, also comprises Caulis et Folium fici Tikouae 7-9 part, Herba veronicastri villosuli
1-2 part.Caulis et Folium fici Tikouae has heat clearing away, dampness removing, invigorates blood circulation, effect of removing toxic substances;Control dysentery, edema, jaundice, rheumatalgia, hemorrhoid
Skin ulcer is hemorrhage, infantile dyspepsia, innominate toxic swelling.Herba veronicastri villosuli has inducing diuresis to remove edema, effect of dissipating blood stasis removing toxic substances;For ascites, water
Swollen, dysuria, traumatic injury;Parotitis, furuncle, burn and scald, venom are controlled in external.The beneficial effect of this programme removes
Outside treatment Mylopharyngodon piceus enteritis disease, also there is dissipating blood stasis removing toxic substances, effect of heat clearing and blood circulation promoting, the malaise symptoms of ill Mylopharyngodon piceus can be alleviated,
Improve recovery from illness speed.
Prioritization scheme two: the optimization as to prioritization scheme one: also include cefotaxime sodium 0.01 part.Cefotaxime sodium is wide spectrum
Antibiotic, the effect to gram-negative bacteria is strong, to Observation on Specificity of Blood-sucking hemophilus influenza, escherichia coli, the white aerobacteria of salmonella Cray
Belong to and proteus mirabilis, neisseria, staphylococcus, streptococcus pneumoniae, streptococcus etc. have the strongest killing action.Cause green grass or young crops
The cause of disease of fish enteritis is addicted to aqueous vapor pseudomonas bacillus, belongs to gram negative bacteria, and Cefotaxime sodium is sensitive, adds cefotaxime
After sodium, can be with the effect of enhancing composition treatment Mylopharyngodon piceus enteritis disease.
Prioritization scheme three: the optimization as to prioritization scheme two: according to mass fraction meter, also includes fosfomycin 0.01 part.Phosphorus is mould
The mechanism of action of element is to combine with a kind of bacteria cell wall synzyme, and hindering antibacterial to utilize has the first of related substance synthetic cell wall
Step reaction, thus suppress the synthesis of bacteria cell wall, play bactericidal action.Fosfomycin is mainly used in the gram-negative bacteria of sensitivity and causes
Urinary tract, skin and the site infection such as soft tissue, intestinal.Add fosfomycin and can further enhance compositions treatment Mylopharyngodon piceus enteritis
Sick effect.
Detailed description of the invention
Below by detailed description of the invention, the present invention is further detailed explanation:
Setup Experiments blank group, matched group, experiment A group, experiment B group, experiment C group, experiment D group, experiment E group, reality
Testing F group, each group with an independent culturing pool.The sick fish that 240 tails suffer from moderate enteritis disease is the most all assigned in eight groups,
Often organize 30 tails.Outside divided by lower process difference, remaining condition is the most identical:
Blank group: not treated with medicaments.
Matched group: bleaching powder full pond float, makes water become the concentration of lmg/L;Take Herba Euphorbiae Humifusae orally simultaneously, by Radix Glycyrrhizae 0.5~
The consumption of lkg/100kg, admixes and feeds fish in feedstuff, every day 1 time, continuous 5 days.
Experiment A group: use compositions, according to mass fraction meter, including Herba Blumeae Densiflorae 8 parts, Sweet Broomwort Herb 12 parts, Herba Patriniae 4 parts,
Herba Sonchi Oleracei 5 parts.
Experiment B group: use compositions, according to mass fraction meter, including Herba Blumeae Densiflorae 12 parts, Sweet Broomwort Herb 8 parts, Herba Patriniae 6 parts,
Herba Sonchi Oleracei 3 parts.
Experiment C group: use compositions, according to mass fraction meter, including Herba Blumeae Densiflorae 11 parts, Sweet Broomwort Herb 9 parts, Herba Patriniae 5 parts,
Herba Sonchi Oleracei 4 parts.Caulis et Folium fici Tikouae 7 parts, Herba veronicastri villosuli 2 parts.
Experiment D group: use compositions, according to mass fraction meter, including Herba Blumeae Densiflorae 9 parts, Sweet Broomwort Herb 11 parts, Herba Patriniae 4.4 parts,
Herba Sonchi Oleracei 3.5 parts, Caulis et Folium fici Tikouae 9 parts, Herba veronicastri villosuli 1 part.
Experiment E group: use compositions, according to mass fraction meter, including Herba Blumeae Densiflorae 10 parts, Sweet Broomwort Herb 8.5 parts, Herba Patriniae 5.6
Part, Herba Sonchi Oleracei 4.7 parts, Caulis et Folium fici Tikouae 8 parts, Herba veronicastri villosuli 1.3 parts, cefotaxime sodium 0.01 part.
Experiment F group: use compositions, according to mass fraction meter, including Herba Blumeae Densiflorae 11.3 parts, Sweet Broomwort Herb 10 parts, Herba Patriniae 5.2
Part, Herba Sonchi Oleracei 3.3 parts, Caulis et Folium fici Tikouae 7.7 parts, Herba veronicastri villosuli 1.7 parts, cefotaxime sodium 0.01 part, fosfomycin 0.01 part.
Wherein, experiment A group to experiment D group, decoct compositions according to the method for decocting herb, obtain medicinal liquid and medicinal residues;By medicinal liquid
According to 0.3L/m3Consumption splash full pond, every day 1 time, continuous 5 days;Powder beaten by medicinal residues, by medicinal residues powder with feedstuff according to 1:10
Ratio throw something and feed Mylopharyngodon piceus, every day 1 time, continuous 5 days.
Experiment E group and the difference testing A group are, splash behind full pond with medicinal liquid, after wait 0.5h, use cefotaxime sodium
Aqueous solution splash full pond.The processing method of medicinal residues powder is identical.
Experiment F group and the difference testing E group are, splash behind full pond with the aqueous solution of cefotaxime sodium, wait 1h, so
Splash full pond with the aqueous solution of fosfomycin afterwards.The processing method of medicinal residues powder is identical.
After 5 days, experimental result is as follows:
Blank group | Matched group | Experiment A group | Experiment B group | Experiment C group | Experiment D group | Experiment E group | Experiment F group | |
Cure (tail) | 0 | 22 | 27 | 26 | 29 | 28 | 29 | 30 |
Take a turn for the better (tail) | 0 | 8 | 2 | 4 | 0 | 2 | 1 | 0 |
Dead (tail) | 27 | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
Result is added up:
Blank group: dead 27 tail, other 3 shape of tail states are very poor, tend to disease and die;Mortality rate 90.0%.
Matched group: cure rate 73.3%, improvement rate 26.7%, mortality rate 6.7%.
Experiment A group: cure rate 90.0%, improvement rate 6.7%, mortality rate 3.3%.
Experiment B group: cure rate 86.7%, improvement rate 13.3%, mortality rate 0.
Experiment C group: cure rate 96.7%, improvement rate 0%, mortality rate 3.3%.
Experiment D group: cure rate 93.3%, improvement rate 6.7%, mortality rate 0.
Experiment E group: cure rate 96.7%, improvement rate 3.3%, mortality rate 0.
Experiment F group: cure rate 100%, improvement rate 0%, mortality rate 0.
Interpretation of result: experiment A group and B group are to have employed the base case of the present invention, experiment C group is to use to experiment F group
The preferred version of base case, the cure rate of these six experimental grouies is all significantly better than the matched group of employing conventional solution, dead
Rate is significantly lower than matched group.As can be seen here, the present invention compared to existing technology, has prominent substantive distinguishing features and significantly progress.
Above-described is only embodiments of the invention, and in scheme, the known general knowledge such as using method and characteristic is too much retouched at this
State.It should be pointed out that, for a person skilled in the art, under the premise of not departing from the present invention, it is also possible to make some changing
Entering, these also should be considered as protection scope of the present invention, and these are all without affecting effect and the practical applicability that the present invention implements.
The protection domain that this application claims should be as the criterion with the content of its claim, and the detailed description of the invention in description etc. is recorded permissible
For explaining the content of claim.
Claims (4)
1. the compositions treating Mylopharyngodon piceus enteritis disease, it is characterised in that: according to mass fraction meter, including Herba Blumeae Densiflorae 8-12 part, ice
Sugar grass 8-12 part, Herba Patriniae 4-6 part, Herba Sonchi Oleracei 3-5 part.
A kind of compositions treating Mylopharyngodon piceus enteritis disease the most according to claim 1, it is characterised in that: according to mass fraction meter,
Also comprise Caulis et Folium fici Tikouae 7-9 part, Herba veronicastri villosuli 1-2 part.
A kind of compositions treating Mylopharyngodon piceus enteritis disease the most according to claim 2, it is characterised in that: according to mass fraction meter,
Also include cefotaxime sodium 0.01 part.
A kind of compositions treating Mylopharyngodon piceus enteritis disease the most according to claim 3, it is characterised in that: according to mass fraction meter,
Also include fosfomycin 0.01 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610362469.9A CN105816565A (en) | 2016-05-27 | 2016-05-27 | Composition for treating enteritis of black carps |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610362469.9A CN105816565A (en) | 2016-05-27 | 2016-05-27 | Composition for treating enteritis of black carps |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105816565A true CN105816565A (en) | 2016-08-03 |
Family
ID=56532297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610362469.9A Pending CN105816565A (en) | 2016-05-27 | 2016-05-27 | Composition for treating enteritis of black carps |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105816565A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106138398A (en) * | 2016-08-22 | 2016-11-23 | 重庆市万州区石人滩农业发展有限公司 | A kind of composition treating silver carp enteritis disease |
CN106689808A (en) * | 2016-12-09 | 2017-05-24 | 陈周英 | Feed for enhancing immunity of black carps |
CN106822240A (en) * | 2016-12-02 | 2017-06-13 | 重庆市长寿区祥金贵淡水鱼养殖场 | A kind of composition for treating variegated carp enteritis disease |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104027507A (en) * | 2014-05-15 | 2014-09-10 | 当涂县科辉商贸有限公司 | Traditional Chinese medicine decoction for treating ulcerative colitis |
CN104758802A (en) * | 2015-03-06 | 2015-07-08 | 钟云仙 | Chinese medicinal composition for treatment of Mylopharyngodon piceus bacterial enteritis |
CN104940370A (en) * | 2015-07-22 | 2015-09-30 | 资源县民生水产养殖有限责任公司 | Traditional Chinese medicine for preventing and treating enteritis of rainbow trouts |
-
2016
- 2016-05-27 CN CN201610362469.9A patent/CN105816565A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104027507A (en) * | 2014-05-15 | 2014-09-10 | 当涂县科辉商贸有限公司 | Traditional Chinese medicine decoction for treating ulcerative colitis |
CN104758802A (en) * | 2015-03-06 | 2015-07-08 | 钟云仙 | Chinese medicinal composition for treatment of Mylopharyngodon piceus bacterial enteritis |
CN104940370A (en) * | 2015-07-22 | 2015-09-30 | 资源县民生水产养殖有限责任公司 | Traditional Chinese medicine for preventing and treating enteritis of rainbow trouts |
Non-Patent Citations (1)
Title |
---|
汪德刚,戴永海 主编: "六、鱼肠炎病", 《中兽医防治技术》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106138398A (en) * | 2016-08-22 | 2016-11-23 | 重庆市万州区石人滩农业发展有限公司 | A kind of composition treating silver carp enteritis disease |
CN106822240A (en) * | 2016-12-02 | 2017-06-13 | 重庆市长寿区祥金贵淡水鱼养殖场 | A kind of composition for treating variegated carp enteritis disease |
CN106689808A (en) * | 2016-12-09 | 2017-05-24 | 陈周英 | Feed for enhancing immunity of black carps |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102835609B (en) | Pig feed capable of preventing piglets from diarrhea and traditional Chinese medicine composition | |
CN103355552A (en) | Mixed feed for carp in fingerling stage and preparation method thereof | |
CN104126737B (en) | A kind of Weanling pig compound feed and preparation method thereof | |
CN104208240A (en) | Traditional Chinese herbal microecological preparation for preventing and treating piglet bacterial dysentery and preparation method thereof | |
CN106509415A (en) | Feed additive capable of improving anti-stress and immunity of ruminants and preparation method thereof | |
CN105831501A (en) | High-yield laying duck compound feed | |
CN105816565A (en) | Composition for treating enteritis of black carps | |
KR102103641B1 (en) | Poultry feed additive manufacturing method | |
CN104855705A (en) | Biological fermentation feed for chicken broilers and preparation method thereof | |
CN104304789A (en) | Chicken feed | |
CN103689276B (en) | Chinese herbal medicine feed additive capable of effectively preventing and treating piglet diarrhea | |
CN104322985A (en) | Piglet feed | |
CN104161874A (en) | Compound traditional Chinese medicine composition for preventing and treating piglet bacillary dysentery and its preparation method and use | |
CN109770081A (en) | A kind of method of microbial flora fermentation pannage | |
CN105053633A (en) | Poultry physique improving Chinese herbal medicinal composite forage and preparation method thereof | |
CN105106725A (en) | Swordtail bacillary enteritis preventing feed additive and preparation method thereof | |
CN105214046A (en) | Preparation for the treatment of Lateolabrax japonicus enteritis disease and preparation method thereof | |
CN107259157A (en) | A kind of feed for preventing and treating pig dysentery disease | |
CN107551042B (en) | Traditional Chinese medicine preparation for preventing and treating chicken salmonella diseases and preparation method and use method thereof | |
CN107125433A (en) | Additive for farm animal feed containing Chinese medicine and preparation method thereof | |
CN105535720A (en) | Chinese herbal medicinal composition for preventing and treating chick bronchitis, and preparation method thereof | |
CN107912640A (en) | A kind of feed for preventing chicken dysentery and preparation method thereof | |
CN105231010A (en) | Chicken feed containing horseradish tree leaves and chicken raising method | |
CN104173556A (en) | Complex preparation for treating prawn enteritis | |
CN109432287A (en) | A kind of traditional Chinese medicine oral liquid and preparation method thereof of prevention and treatment poultry excessive heat in the system card |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160803 |